Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca)

J Formos Med Assoc. 2022 Oct;121(10):2138-2140. doi: 10.1016/j.jfma.2022.03.006. Epub 2022 Apr 2.

Authors

Hsuan-An Su¹, Chih-Kai Juan², Yu-Chia Chen³

Affiliations

¹ Department of Dermatology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
² Department of Plastic and Aesthetic Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
³ Department of Dermatology, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Electronic address: ccyycc2408@gmail.com.

PMID: 35379574
DOI: 10.1016/j.jfma.2022.03.006

No abstract available

Publication types

Letter

MeSH terms

Alopecia Areata* / chemically induced
ChAdOx1 nCoV-19
Humans
Vaccination / adverse effects

Substances

ChAdOx1 nCoV-19

Supplementary concepts

Diffuse alopecia